FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kenneth van Golen

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Physiology

Living Beings

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
Heather L Lehman; Michelle Lucey; Erica J Dashner; Luc Dirix; Peter B Vermeulen; Steven Van Laere; Kenneth L van Golen
Modeling and characterization of inflammatory breast cancer emboli grown in vitro.
Rebecca L Hillyer; Madhura Joglekar; Robert A Sikes; Padma Sirinvasin; Kenneth L van Golen; Anja Nohe
Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines.
John Mills; Alice Oliver; Michael Bailey; Anthony Costello; Mark Frydenberg; Laurence Harewood; Christopher Love; Justin S Peters; Nicholas Redgrave; Justin C Sherwin; Kenneth L van Golen; John Pedersen
Utility of RhoC and ZAG protein expression as biomarkers for prediction of PSA failure following radical prostatectomy for high grade prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kenneth van Golen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Heather L Lehman; Michelle Lucey; Erica J Dashner; Luc Dirix; Peter B Vermeulen; Steven Van Laere; Kenneth L van Golen
Modeling and characterization of inflammatory breast cancer emboli grown in vitro.
International journal of cancer. Journal international du cancer 2013;132(10):2283-94.
2012: Rebecca L Hillyer; Madhura Joglekar; Robert A Sikes; Padma Sirinvasin; Kenneth L van Golen; Anja Nohe
Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines.
Clinical & experimental metastasis 2012;29(8):971-9.
2012: John Mills; Alice Oliver; Michael Bailey; Anthony Costello; Mark Frydenberg; Laurence Harewood; Christopher Love; Justin S Peters; Nicholas Redgrave; Justin C Sherwin; Kenneth L van Golen; John Pedersen
Utility of RhoC and ZAG protein expression as biomarkers for prediction of PSA failure following radical prostatectomy for high grade prostate cancer.
Pathology 2012;44(6):513-8.
2012: Heather L Lehman; Cynthia M van Golen; Steven J Van Laere; Peter B Vermeulen; Luc Y Dirix; Kenneth L van Golen
Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPase.
Molecular cancer research : MCR 2012;10(10):1306-18.
2012: Breonna J Martin; Kenneth L van Golen
A comparison of cholesterol uptake and storage in inflammatory and noninflammatory breast cancer cells.
International journal of breast cancer 2012;2012():412581.
2012: Lisa A Gurski; Xinqiao Jia; Lyana N Labrada; Ngoc T Nguyen; Kenneth L van Golen; Longxi Xiao; Xian Xu; Mary C Farach-Carson
Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels.
PloS one 2012;7(11):e50075.
2011: Moumita Chatterjee; Kenneth L van Golen
Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype.
International journal of cancer. Journal international du cancer 2011;129(1):61-9.
2011: Moumita Chaterjee; Kenneth L van Golen
Breast cancer stem cells survive periods of farnesyl-transferase inhibitor-induced dormancy by undergoing autophagy.
Bone marrow research 2011;2011():362938.
2011: Moumita Chatterjee; Cara W Dubyk; Mashariki Jenkins-Kabaila; Surabhi Pathak; Linda Sequeira; Kenneth L van Golen
Individual rac GTPases mediate aspects of prostate cancer cell and bone marrow endothelial cell interactions.
Journal of signal transduction 2011;2011():541851.
2010: Peter B Vermeulen; Kenneth L van Golen; Luc Y Dirix
Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge.
Cancer 2010;116(11 Suppl):2748-54.
2010: Michelle Lucey; Heather Unger; Kenneth L van Golen
RhoC GTPase activation assay.
Journal of visualized experiments : JoVE 2010;(42):.
2008: Carlton R Cooper; Bianca Graves; Freddie Pruitt; Hassan Chaib; Jill E Lynch; Andrew Koemeter Cox; Linda Sequeria; Kenneth L van Golen; Angelo Evans; Kirk Czymmek; Rebecca Linton; Carlton D Donald; Katia Sol-Church; James D Gendernalik; Babette Weksler; Mary C Farach-Carson; Jill A Macoska; Robert A Sikes; Kenneth Pienta
Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha.
Journal of cellular biochemistry 2008;104(6):2298-309.
2008: Christopher L Hall; Cara W Dubyk; Tracy A Riesenberger; Daniel Shein; Evan T Keller; Kenneth L van Golen
Type I collagen receptor (alpha2beta1) signaling promotes prostate cancer invasion through RhoC GTPase.
Neoplasia (New York, N.Y.) 2008;10(8):797-803.
2008: Kenneth L van Golen; Chi Ying; Linda Sequeira; Cara W Dubyk; Tracy Reisenberger; Arul M Chinnaiyan; Kenneth Pienta; Robert D Loberg
CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase Rac.
Journal of cellular biochemistry 2008;104(5):1587-97.
2008: Linda Sequeira; Cara W Dubyk; Tracy A Riesenberger; Carlton R Cooper; Kenneth L van Golen
Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis.
Clinical & experimental metastasis 2008;25(5):569-79.
2008: Fayth L Miles; Freddie L Pruitt; Kenneth L van Golen; Carlton R Cooper
Stepping out of the flow: capillary extravasation in cancer metastasis.
Clinical & experimental metastasis 2008;25(4):305-24.
2006: Kenneth L van Golen
Is caveolin-1 a viable therapeutic target to reduce cancer metastasis?
Expert opinion on therapeutic targets 2006;10(5):709-21.
2006: Christopher L Hall; Jinlu Dai; Kenneth L van Golen; Evan T Keller; Michael W Long
Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.
Cancer research 2006;66(17):8648-54.
2006: Cynthia M van Golen; Tracy S Schwab; BHumsoo Kim; Mary E Soules; Sang Su Oh; Kinwah Fung; Kenneth L van Golen; Eva L Feldman
Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone.
Cancer research 2006;66(13):6570-8.
2006: H Yao; E J Dashner; Cynthia M van Golen; Kenneth L van Golen
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility.
Oncogene 2006;25(16):2285-96.
2006: Steven J Van Laere; Gert G Van den Eynden; Ilse Van der Auwera; Melanie Vandenberghe; Peter van Dam; Eric A Van Marck; Kenneth L van Golen; Peter B Vermeulen; Luc Y Dirix
Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
Breast cancer research and treatment 2006;95(3):243-55.
2006: Gert G Van den Eynden; Steven J Van Laere; Ilse Van der Auwera; Sofia D Merajver; Eric A Van Marck; Peter van Dam; Peter B Vermeulen; Luc Y Dirix; Kenneth L van Golen
Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Breast cancer research and treatment 2006;95(3):219-28.
2006: Lizhi Zhang; Li Chenwei; Redah Mahmood; Kenneth L van Golen; Joel K Greenson; Gangyong Li; Nisha J D'Silva; Xiangquan Li; Charles F Burant; Craig D Logsdon; Diane M Simeone
Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer.
Cancer research 2006;66(2):898-906.
2005: Xihong Zhang; Min Lin; Kenneth L van Golen; Kiyoko Yoshioka; Kazuyuki Itoh; Douglas Yee
Multiple signaling pathways are activated during insulin-like growth factor-I (IGF-I) stimulated breast cancer cell migration.
Breast cancer research and treatment 2005;93(2):159-68.
2005: Celina G Kleer; Kent Andrew Griffith; Michael Sabel; Gary Gallagher; Kenneth L van Golen; Zhi-Fen Wu; Sofia D Merajver
RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.
Breast cancer research and treatment 2005;93(2):101-10.
2005: Thiruvengadam Arumugam; Diane M Simeone; Kenneth L van Golen; Craig D Logsdon
S100P promotes pancreatic cancer growth, survival, and invasion.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(15):5356-64.
2005: Galina S Radunsky; Kenneth L van Golen
The current understanding of the molecular determinants of inflammatory breast cancer metastasis.
Clinical & experimental metastasis 2005;22(8):615-20.
2005: Min Lin; Melinda M DiVito; Sofia D Merajver; Madanamohan Boyanapalli; Kenneth L van Golen
Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1.
Molecular cancer 2005;4(1):21.
2004: Amy Meyer; Cynthia M van Golen; BHumsoo Kim; Kenneth L van Golen; Eva L Feldman
Integrin expression regulates neuroblastoma attachment and migration.
Neoplasia (New York, N.Y.) 2004;6(4):332-42.
2004: Min Lin; Kenneth L van Golen
Rho-regulatory proteins in breast cancer cell motility and invasion.
Breast cancer research and treatment 2004;84(1):49-60.
2003: Kenneth L van Golen
Inflammatory breast cancer: relationship between growth factor signaling and motility in aggressive cancers.
Breast cancer research : BCR 2003;5(3):174-9.
2002: Quintin Pan; Celina G Kleer; Kenneth L van Golen; Jennifer Irani; Kristen M Bottema; Carlos Bias; Magda De Carvalho; Enrique Mesri; Diane M Robins; Robert D Dick; George J Brewer; Sofia D Merajver
Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.
Cancer research 2002;62(17):4854-9.
2002: Kenneth L van Golen; LiWei Bao; George J Brewer; Kenneth Pienta; Jeffrey M Kamradt; Donna L Livant; Sofia D Merajver
Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.
Neoplasia (New York, N.Y.) 2002;4(5):373-9.
2002: Daniel Noujaim; Cynthia M van Golen; Kenneth L van Golen; Alyssa R Grauman; Eva L Feldman
N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells.
Oncogene 2002;21(29):4549-57.
2002: Celina G Kleer; Michael D Tseng; David E Gutsch; Rosemary Rochford; Zhifen Wu; Lynn K Joynt; Mark A Helvie; Tammy Chang; Kenneth L van Golen; Sofia D Merajver
Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(7):759-64.
2002: Kenneth L van Golen; LiWei Bao; Melinda M DiVito; ZhiFen Wu; George C Prendergast; Sofia D Merajver
Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor.
Molecular cancer therapeutics 2002;1(8):575-83.
2002: Celina G Kleer; Yanhong Zhang; Quintin Pan; Kenneth L van Golen; Zhi-Fen Wu; Donna L Livant; Sofia D Merajver
WISP3 is a novel tumor suppressor gene of inflammatory breast cancer.
Oncogene 2002;21(20):3172-80.
2002: Dr. Muhammad Khan; Meredith W Miller; Jeremy Taylor; Navkiranjit K Gill; Robert D Dick; Kenneth L van Golen; George J Brewer; Sofia D Merajver
Radiotherapy and antiangiogenic TM in lung cancer.
Neoplasia (New York, N.Y.) 2002;4(2):164-70.
2002: Celina G Kleer; Kenneth L van Golen; Yanhong Zhang; Zhi-Fen Wu; Mark A Rubin; Sofia D Merajver
Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability.
The American journal of pathology 2002;160(2):579-84.
2002: Kenneth L van Golen; Li Wei Bao; Quintin Pan; Fred R Miller; Zhi-Fen Wu; Sofia D Merajver
Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer.
Clinical & experimental metastasis 2002;19(4):301-11.
2001: Celina G Kleer; Kenneth L van Golen; T Braun; Sofia D Merajver
Persistent E-cadherin expression in inflammatory breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(5):458-64.
2000: Kenneth L van Golen; Zhi-Fen Wu; Xiaotan T Qiao; Li Wei Bao; Sofia D Merajver
RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
Cancer research 2000;60(20):5832-8.
2000: Kenneth L van Golen; Zhi-Fen Wu; Xiaotan T Qiao; Li Wei Bao; Sofia D Merajver
RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.
Neoplasia (New York, N.Y.) 2000;2(5):418-25.
2000: Celina G Kleer; Kenneth L van Golen; Sofia D Merajver
Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants.
Breast cancer research : BCR 2000;2(6):423-9.
1999: Kenneth L van Golen; S Davies; Zhi-Fen Wu; Yihan Wang; C D Bucana; H Root; S Chandrasekharappa; Myla S Strawderman; Stephen Ethier; Sofia D Merajver
A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2511-9.
1999: Kenneth L van Golen; Kara J Milliron; S Davies; Sofia D Merajver
BRCA-associated cancer risk: molecular biology and clinical practice.
The Journal of laboratory and clinical medicine 1999;134(1):11-8.
1998: Laurie B Owen-Schaub; Kenneth L van Golen; Laurie L Hill; Janet E Price
Fas and Fas ligand interactions suppress melanoma lung metastasis.
The Journal of experimental medicine 1998;188(9):1717-23.
1997: KR Brader; Judith K Wolf; Mien-Chie Hung; Dihua Yu; Marta Crispens; Kenneth L van Golen; Janet E Price
Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(11):2017-24.
1996: Kenneth L van Golen; S Risin; A Staroselsky; D Berger; Michael A Tainsky; Sen Pathak; Janet E Price
Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones.
Clinical & experimental metastasis 1996;14(2):95-106.